FI61703C - Foerfarande foer framstaellning av farmakologiskt vaerdefulla hydroxialkylxantiner - Google Patents
Foerfarande foer framstaellning av farmakologiskt vaerdefulla hydroxialkylxantiner Download PDFInfo
- Publication number
- FI61703C FI61703C FI2065/74A FI206574A FI61703C FI 61703 C FI61703 C FI 61703C FI 2065/74 A FI2065/74 A FI 2065/74A FI 206574 A FI206574 A FI 206574A FI 61703 C FI61703 C FI 61703C
- Authority
- FI
- Finland
- Prior art keywords
- compounds
- carbon atoms
- group
- xanthine
- methyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
- C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
- C07D473/10—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 3 and 7, e.g. theobromine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2335170 | 1973-07-11 | ||
DE2335170A DE2335170C2 (de) | 1973-07-11 | 1973-07-11 | 1,3-Dialkyl-7-(hydroxyalkyl)-xanthine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel |
Publications (3)
Publication Number | Publication Date |
---|---|
FI206574A FI206574A (fr) | 1975-01-12 |
FI61703B FI61703B (fi) | 1982-05-31 |
FI61703C true FI61703C (fi) | 1982-09-10 |
Family
ID=5886518
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI2065/74A FI61703C (fi) | 1973-07-11 | 1974-07-05 | Foerfarande foer framstaellning av farmakologiskt vaerdefulla hydroxialkylxantiner |
Country Status (17)
Country | Link |
---|---|
US (1) | US4108995A (fr) |
AR (4) | AR199915A1 (fr) |
AT (1) | AT333300B (fr) |
BE (1) | BE816869R (fr) |
CA (1) | CA1062709A (fr) |
CH (4) | CH587850A5 (fr) |
DE (1) | DE2335170C2 (fr) |
DK (1) | DK147004C (fr) |
ES (3) | ES417828A1 (fr) |
FI (1) | FI61703C (fr) |
FR (1) | FR2236501B2 (fr) |
GB (1) | GB1480836A (fr) |
IE (1) | IE41822B1 (fr) |
NL (1) | NL168703C (fr) |
NO (2) | NO140596C (fr) |
SE (1) | SE415354B (fr) |
ZA (1) | ZA744373B (fr) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4207321A (en) * | 1977-04-02 | 1980-06-10 | Hoechst Aktiengesellschaft | Pharmaceutical compositions containing xanthines |
DE3138397A1 (de) * | 1981-09-26 | 1983-04-07 | Hoechst Ag, 6230 Frankfurt | "arzneimittel, darin enthaltene vicinale dihydroxyalkylxanthine und herstellungsverfahren fuer diese xanthinverbindungen" |
US4636507A (en) * | 1984-04-30 | 1987-01-13 | Hoechst-Roussel Pharmaceuticals Inc. | Host defense mechanism enhancement |
DE3525801A1 (de) * | 1985-07-19 | 1987-01-22 | Hoechst Ag | Tertiaere hydroxyalkylxanthine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung |
US5338741A (en) * | 1986-10-27 | 1994-08-16 | Nestec S.A. | 1-hydroxyalkylxanthines and medicaments containing them |
DE3725554A1 (de) * | 1987-08-01 | 1989-02-09 | Hoechst Ag | Pharmazeutisches kombinationspraeparat sowie dessen herstellung und verwendung |
DE3942871A1 (de) * | 1989-12-23 | 1991-06-27 | Hoechst Ag | R-(-)-1-(5-hydroxyhexyl)-3-methyl-7-propylxanthin, verfahren zu dessen herstellung und diese verbindung enthaltende arzneimittel |
EP0570831A2 (fr) * | 1992-05-20 | 1993-11-24 | Hoechst Aktiengesellschaft | Utilisation de dérivés de Xanthine pour le traitement de dommages cérébraux après interruption de la circulation sanguine |
US5856330A (en) * | 1996-07-31 | 1999-01-05 | Hoechst Aktiengesellschaft | Use of xanthine derivatives for the inhibition of dephosphorylation of cofilin |
US5981536A (en) * | 1996-07-31 | 1999-11-09 | Hoechst Aktiengesellschaft | Use of xanthine derivatives for the modulation of apoptosis |
WO1999031101A1 (fr) * | 1997-12-17 | 1999-06-24 | University Of South Florida | Antagonistes du recepteur de l'adenosine presentant une bioactivite amelioree |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2756229A (en) * | 1956-07-24 | Xanthine derivatives | ||
US2517410A (en) * | 1947-08-15 | 1950-08-01 | Searle & Co | Hydroxy alkyl xanthines and the production thereof |
DE926788C (de) * | 1952-11-07 | 1955-04-25 | Geigy Ag J R | Verfahren zur Herstellung von 1, 3-dialkylierten 7-Oxyalkyl-xanthinabkoemmlingen |
FR1211333A (fr) * | 1955-10-19 | 1960-03-15 | Boehringer Sohn Ingelheim | Perfectionnements apportés aux procédés pour fabriquer des oxyalcoylxanthines |
DE1810705C3 (de) * | 1968-11-25 | 1980-11-27 | Hoechst Ag, 6000 Frankfurt | Stabilisierung von Vitaminen |
DE1911279A1 (de) * | 1969-03-05 | 1970-11-12 | Eckert Dr Theodor | Verfahren zur Erhoehung der Resorptionsfaehigkeit von Arzneistoffen |
-
1973
- 1973-07-11 DE DE2335170A patent/DE2335170C2/de not_active Expired
- 1973-08-02 CH CH1124073A patent/CH587850A5/xx not_active IP Right Cessation
- 1973-08-02 CH CH1602576A patent/CH587853A5/xx not_active IP Right Cessation
- 1973-08-02 CH CH1602376A patent/CH587852A5/xx not_active IP Right Cessation
- 1973-08-02 CH CH1602476A patent/CH587851A5/xx not_active IP Right Cessation
- 1973-08-03 AT AT684573A patent/AT333300B/de not_active IP Right Cessation
- 1973-08-09 DK DK438373A patent/DK147004C/da not_active IP Right Cessation
- 1973-08-10 NL NLAANVRAGE7311123,A patent/NL168703C/xx not_active IP Right Cessation
- 1973-08-10 CA CA178,591A patent/CA1062709A/fr not_active Expired
- 1973-08-10 AR AR249530A patent/AR199915A1/es active
- 1973-08-10 SE SE7310986A patent/SE415354B/xx unknown
- 1973-08-11 ES ES417828A patent/ES417828A1/es not_active Expired
-
1974
- 1974-06-26 BE BE145889A patent/BE816869R/fr not_active IP Right Cessation
- 1974-06-28 GB GB28866/74A patent/GB1480836A/en not_active Expired
- 1974-07-05 US US05/485,869 patent/US4108995A/en not_active Expired - Lifetime
- 1974-07-05 NO NO742464A patent/NO140596C/no unknown
- 1974-07-05 FI FI2065/74A patent/FI61703C/fi active
- 1974-07-08 FR FR7423606A patent/FR2236501B2/fr not_active Expired
- 1974-07-08 ZA ZA00744373A patent/ZA744373B/xx unknown
- 1974-07-09 IE IE1456/74A patent/IE41822B1/en unknown
- 1974-10-01 AR AR255873A patent/AR202663A1/es active
- 1974-10-01 AR AR255874A patent/AR200626A1/es active
- 1974-10-01 AR AR255872A patent/AR202662A1/es active
-
1975
- 1975-04-29 ES ES437151A patent/ES437151A1/es not_active Expired
- 1975-04-29 ES ES437150A patent/ES437150A1/es not_active Expired
-
1979
- 1979-02-23 NO NO790627A patent/NO143064C/no unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4289776A (en) | Xanthine derivatives | |
FI89921B (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara tertiaera hydroxialkylxantiner | |
FI61703C (fi) | Foerfarande foer framstaellning av farmakologiskt vaerdefulla hydroxialkylxantiner | |
EP0028834B1 (fr) | Dérivés de l'acide imidazole-5-acétique, procédé pour leur préparation et leur utilisation | |
EP0103497B1 (fr) | Nouveaux dérivés de la xanthine, leur procédé de préparation et les compositions pharmaceutiques les renfermant | |
EP0051829A1 (fr) | Acides oméga-(2-oxo-4-imidazolin-1-yl)alcanoiques N-substitués, leurs sels et esters, leur procédé de fabrication et compositions pharmaceutiques contenant ces substances actives | |
PL163884B1 (pl) | Sposób wytwarzania fluoksetyny PL PL PL | |
JPS62116583A (ja) | プリン誘導体 | |
JPH0222075B2 (fr) | ||
US3734911A (en) | Dialkyl-xanthine derivatives | |
ITMI941494A1 (it) | Derivati del fenilcarbammato atti all'impiego come anticolinesterasici | |
Montgomery et al. | Synthesis of potential anticancer agents. XXX.(1-Aziridinyl) purines | |
US5314890A (en) | 1-7 disubstituted xanthine derivatives having antiasthmatic activity, their physiologically acceptable salts, pharmaceutical compositions containing them and process for their preparation | |
CA1075237A (fr) | Derives de la purine | |
US4512990A (en) | Benzthiazine analogs as antiinflammatory agents | |
US3905990A (en) | Basically substituted benzimidazole derivatives | |
RU2159617C2 (ru) | Производные ксантина, их стереоизомеры и физиологически переносимые соли, фармацевтическая композиция, обладающая уменьшающей патологическую гиперактивность эозинофильных гранулятов активностью | |
US3926995A (en) | Theophylline derivatives | |
JPS6141915B2 (fr) | ||
CA1086316A (fr) | Nucleosides acycliques de purine | |
HU187650B (en) | Process for preparing of new 12-substituated carbamide derivatives of ergolins | |
KR930010559B1 (ko) | 1-히드록시알킬크산틴류, 그의 제조방법 | |
US3414572A (en) | Basic substituted alkylxanthine derivatives | |
DE2366527C2 (fr) | ||
GB1561380A (en) | Esters of hydroxyalkoxyalkyl purines their preparation and pharmaceutical compositions containing them |